Für diesen Artikel ist leider kein Bild verfügbar.

Challenges in Prostate Cancer

Winsor Bowsher (Herausgeber)

Buch | Hardcover
248 Seiten
2000
Blackwell Science Ltd (Verlag)
978-0-632-05422-0 (ISBN)
65,45 inkl. MwSt
zur Neuauflage
  • Titel erscheint in neuer Auflage
  • Artikel merken
Zu diesem Artikel existiert eine Nachauflage
This text considers the state of prostate cancer research, diagnosis and treatment at the end of the 20th century. It is divided into four sections: biological and scientific aspects; diagnosis and evaluation; initial treatment policies; and monitoring progress and secondary treatment.
Prostate cancer continues to be a major threat to men's health, being the second most common cancer in men in many countries. Every year it causes approximately 35,000 deaths in Europe and 38,000 in the US, and the incidence is rising. For the foreseeable future, prostate cancer will remain an important part of the urologist's workload and it will therefore be increasingly important that those faced with the difficult clinical decisions, make the right choices. There are no fewer controversies in the science and clinical management of prostate cancer since publication of the first volume in this series Questions and Uncertainties in Prostate Cancer. Time has moved on, some questions have been answered, many remain, and new areas of uncertainty have been uncovered. Challenges in Prostate Cancer provides a new selection of state-of-the-art review articles, each of which addresses a contentious question. Edited by a leading authority in the field, the book contains the contributions of some 24 well-respected clinicians and researchers whose expertise is used to distil the available evidence into practical advice that can be used by urologists in their day-to-day practice.

PART 1: BIOLOGICAL AND SCIENTIFIC ASPECTS 1 What diet is necessary for the prevention of prostate cancer? 2 The role of genes and a family history of prostate cancer 3 Biotechnology and prostate cancer 4 Current Council of the European Organisation for Research and Treatment of Cancer (EORTC) Trials PART 2: DIAGNOSIS AND EVALUATION 5 Does prostate cancer screening detect potentially treatable prostate cancers? 6 New ultrasound media for prostate cancer imaging: will they help? 7 What should a patient be told? a patients perspective PART 3: INITIAL TREATMENT POLICIES 8 Maximal androgen blockade? 9 What is the role of radical perineal prostatectomy? 10 Radiotherapy for T3 prostate cancer? 11 What are the roles of brachytherapy and new radiotherapy techniques? 12 Does orchidectomy still have a role in prostate cancer treatment? 13 What are the economics of prostate cancer treatment? 14 The management of hormone refractory prostate cancer. what is the Importance PART 4: MONITORING PROGRESS AND SECONDARY TREATMENT 15 What palliative care for prostate cancer patients? 16 How should you treat sexual dysfunction after radical prostatectomy?

Erscheint lt. Verlag 6.11.2000
Zusatzinfo 61
Verlagsort Oxford
Sprache englisch
Maße 172 x 244 mm
Gewicht 750 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Urologie
ISBN-10 0-632-05422-0 / 0632054220
ISBN-13 978-0-632-05422-0 / 9780632054220
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00

von Stein Husebø; Gebhard Mathis; Eva Katharina Masel

Buch | Softcover (2023)
Springer (Verlag)
49,99